Telesis Bio, Inc.
OTC: TBIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Eric Esser
- Employees
- 39
- Headquarters
- Lexington, United States
- IPO year
- 2021
- Market cap
- $78.4K
- Website
- https://codexdna.com
Loading TBIO…
Loading profile data…Frequently asked questions about TBIO
What does Telesis Bio, Inc. (TBIO) do?
Telesis Bio, Inc., formerly known as Codex DNA, Inc. (and SGI-DNA, Inc. prior to that), is a San Diego, California-based synthetic biology company established in 2011. The company provides a comprehensive suite of instruments, reagents, and services for synthetic biology applications, catering primarily to pharmaceutical and academic laboratorie...
Where does TBIO trade?
Telesis Bio, Inc. (TBIO) trades on the Other OTC.
What sector is TBIO in?
Telesis Bio, Inc. (TBIO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Telesis Bio, Inc.?
Eric Esser is the chief executive officer of Telesis Bio, Inc. (TBIO).
Where is Telesis Bio, Inc. headquartered?
Telesis Bio, Inc. is headquartered in United States.
Does TBIO pay a dividend?
Telesis Bio, Inc. (TBIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TBIO go public?
Telesis Bio, Inc. (TBIO) completed its initial public offering in 2021.